WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tarsus Pharmaceuticals earnings were -$134.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TARS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$23.4M, down 29.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TARS reported annual earnings of -$135.9M, with 118.9% growth. The next TARS earnings date is Feb 25, 2025.

TARS earnings history

Current Revenue
$129.6M
Current Earnings
-$134.3M
Current Profit Margin
-103.6%

TARS Return on Equity

Current Company
-55.9%
Current Industry
19.9%
Current Market
35%
TARS's Return on Equity (-55.9%)... subscribe to Premium to read more.
High Return on Equity Performance

TARS Return on Assets

Current Company
-39.3%
Current Industry
1.3%
TARS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TARS announces earnings.

TARS Return on Capital Employed

Current Company
-41.17%
Current Industry
14.3%
TARS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TARS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TARS-$126.08M-$134.34MN/A-$3.77
JANX-$58.46M-$60.54MN/A-$1.16
IDYA-$173.91M-$178.12MN/A-$2.33
AGIO$744.44M$674.31M-78.17%$11.79
CGON-$75.16M-$78.29MN/A-$5.30
View Top Biotech Stocks

TARS earnings dates

Next earnings date
Feb 25, 2025

Tarsus Pharmaceuticals Earnings Reports & History FAQ

What were Tarsus Pharmaceuticals's earnings last quarter?

On TARS's earnings call on Invalid Date, Tarsus Pharmaceuticals (NASDAQ: TARS) reported Q3 2024 earnings per share (EPS) of -$0.61, up 52.34% year over year. Total TARS earnings for the quarter were -$23.42 million. In the same quarter last year, Tarsus Pharmaceuticals's earnings per share (EPS) was -$1.28.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.

When does Tarsus Pharmaceuticals report earnings?

The next TARS earnings date is Invalid Date. Add TARS to your watchlist to be reminded of Tarsus Pharmaceuticals's next earnings date.

What was TARS's earnings growth in the past year?

As of Tarsus Pharmaceuticals's earnings date in Invalid Date, Tarsus Pharmaceuticals's earnings has grown year over year. TARS earnings in the past year totalled -$134.34 million.

Is Tarsus Pharmaceuticals profitable or losing money?

As of the last Tarsus Pharmaceuticals earnings report, Tarsus Pharmaceuticals is currently losing money. Tarsus Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$134.34 million, a 24.87% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.